Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 184

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 184
---
 60 days from closing of the offering; and (iv) indemnification for breach of contract. The nature of the representations, warranties and covenants in the securities purchase agreements shall include:

| ● | standard                                                                                                                            
 issuer representations and warranties on matters such as organization, qualification, authorization, no conflict, no governmental   
 filings required, current in SEC filings, no litigation, labor or other compliance issues, environmental, intellectual property and 
 title matters and compliance with various laws such as the Foreign Corrupt Practices Act; and                                       |

| ● | covenants                                                                                                                               
 regarding matters such as registration of warrant shares, no integration with other offerings, no stockholder rights plans, no material 
 nonpublic information, use of proceeds, indemnification of purchasers, reservation and listing of shares of Common Stock, and no        
 subsequent equity sales for 45 days, subject to certain exceptions.                                                                     |

This offering will terminate on May 15, 2025, unless we decide to terminate the offering (which we may do at any time in our discretion) prior to that date. We will have one closing for all the securities purchased in this offering. The combined public offering price per share (or Pre-Funded Warrant) and May 2025 Warrants will be fixed for the duration of this offering.

We expect to deliver the shares and other securities to the purchasers in the offering on or about May 7, 2025, subject to satisfaction of certain conditions. There is no minimum number of securities or amount of proceeds that is a condition to closing of this offering.

Fees and Expenses

The following table shows the per share and accompanying May 2025 Warrants and per Pre-Funded Warrant and accompanying May 2025 Warrants Placement Agent fees we will pay in connection with the sale of the securities in this offering, assuming the purchase of all of the securities we are offering.

|                                    |     |   |                            Per 
 Share and   accompanying   May 
                   2025 Warrant |     |   |                      Per 
     Pre-Funded   Warrant 
 and   accompanying   May 
             2025 Warrant |     |   |              |
|:-----------------------------------|:----|:--|-------------------------------:|:----|:--|-------------------------:|:----|:--|-------------:|
| Public offering price              |     | $ |                           0.32 |     | $ |                    0.313 |     | $ | 3,233,400.